Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, it demonstrated remarkable efficacy in the SURMOUNT-1 clinical trial, where participants achieved 16 to 22.5 percent body weight loss over 72 weeks depending on dose
GLP-1 medications require dose escalation over weeks to reach therapeutic targets, with weekly injections or daily oral dosing
2024 Jul 31;44
staying well-hydrated
Tirzepatide does reduce liver fat the SURMOUNT and SURPASS programs reported meaningful improvements but the magnitude appears to be less than what the glucagon-containing compounds achieve
US$ 22.75
US$ 21.94
US$ 26.91
US$ 27.55
